Mark Johnson is a seasoned professional in biomedical research with extensive experience in pre-clinical research and safety assessment. Currently serving as Chief Scientific Officer and Vice President of Safety Assessment at Northern Biomedical Research since September 2019, Mark Johnson focuses on innovative approaches to targeted delivery of pharmaceuticals, gene, and cell therapies to address unmet medical needs. Prior to this role, Mark Johnson worked at MPI Research for nearly two decades, ascending from Senior Study Director to Senior Director of Surgery. Earlier career experiences include a Research Associate position at the University of Michigan and studying at Eastern Michigan University, where Mark Johnson earned a Master of Science in Psychology.
This person is not in any teams
This person is not in any offices
NorthernBio
At Northern Bio, better lives begin with science. We go beyond the conventional, applying advanced surgical techniques and research methodologies to target the source of the disease, thereby maximizing their impact and potential to transform lives. Just We are more than just our research. We are a collaborative community of scientists who believe in open communication, transparency, and strong partnerships. We partner with our sponsors, offering tailored solutions and expert guidance at every step. Our commitment to excellence, responsibility, and trust is unwavering, guiding us as we tackle some of the most challenging conditions in human health. With every experiment, every analysis, every discovery, we strive to make a difference. We’re driven by a desire to serve those in need, safeguard human and animal health, and push the boundaries of scientific knowledge. At Northern Bio, possibilities become reality, and better lives begin.